Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...
This is a preview. Log in through your library . Abstract When massively expressed in bacteria, recombinant proteins often tend to misfold and accumulate as soluble and insoluble nonfunctional ...
The demand for the manufacturing of polypeptides has radically increased since the recent introduction of new diabetes, obesity and cardiovascular disease peptide drugs. Consequently, peptide API ...
Notification: The Recombinant Protein Production and Characterization (RPPC) Core has undergone reorganization as of January 2026. The previous Macromolecular X-Ray Crystallography Core has been ...
Forbes contributors publish independent expert analyses and insights. Scott Hutcheson teaches leadership at Purdue University. Faced with a crowded dining room and dwindling supplies, Cardini ...
The clinical diagnostic industry is on the verge of a recombinant protein revolution. Recombinants have been available for decades and have served some sectors of diagnostics quite well, but they have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results